Annual Meeting of the American Association of Immunologists
Representatives from the Mashayekhi Lab participated in the Annual Meeting of the American Association of Immunologists (AAI), held May 3–7, 2025, at the Hawaiʻi Convention Center in Honolulu.…
Vanderbilt Digestive Diseases Research Center Retreat
Principal Investigator Dr. Mona Mashayekhi gave a talk at the Vanderbilt Digestive Diseases Research Center Retreat on April 16, 2025. Her presentation, “Immunologic Effects of GLP-1 Receptor…
Study shows liraglutide results in increased insulin sensitivity independent of weight loss
A new study published in the journal Diabetes demonstrates that a glucagon-like peptide-1 receptor (GLP-1R) agonist, a member of a class of medication used to treat Type 2 diabetes and obesity,…
Immune system’s role in metabolic disease detailed in tissue atlas
Researchers at Vanderbilt University Medical Center, including Mona Mashayekhi, MD, PhD, have published the largest known single-site adipose tissue atlas — a comprehensive, detailed map of the…
Diabetes drug may improve asthma
New biomarker finding strengthens the case for using GLP-1R agonists to treat patients with Type 2 diabetes who also suffer from asthma.